Clyde Francks leads the Imaging Genomics research group at the Max Planck Institute, Nijmegen, The Netherlands. His group studies the genetics of language, brain disorders and laterality of the brain. He is also an Affiliated Principal Investigator at the Donders Institute for Brain, Cognition & Behaviour.
Clyde Francks graduated in zoology from the University of Oxford in 1996. He then moved to the Wellcome Trust Centre for Human Genetics, Oxford, where he obtained his doctorate (Wellcome Trust Prize student, DPhil 2002) and stayed as a postdoctoral researcher until 2005. During these years he investigated the genetics of dyslexia and led a project on the genetics of handedness and schizophrenia. From 2005 he continued as a visiting fellow at Oxford while working as a manager in the pharmaceuticals industry (GlaxoSmithKline, Verona, Italy), during which time he led collaborative academia-industry projects on the genetics of schizophrenia and cigarette smoking. In 2010 he started in his current position at the Max Planck Institute, Nijmegen.